Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements
Recently, we demonstrated that hematopoietic stem/progenitor cell (HSPC) mobilization followed by intravenous injection of integrating, helper-dependent adenovirus HDAd5/35++ vectors resulted in efficient transduction of long-term repopulating cells and disease amelioration in mouse models after in...
Main Authors: | Hongjie Wang, Aphrodite Georgakopoulou, Chang Li, Zhinan Liu, Sucheol Gil, Ashvin Bashyam, Evangelia Yannaki, Achilles Anagnostopoulos, Amit Pande, Zsuzsanna Izsvák, Thalia Papayannopoulou, André Lieber |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2020-08-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.139538 |
Similar Items
-
HDAd5/35++ Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR/Cas9 Toxicity in Human Hematopoietic Stem Cells
by: Chang Li, et al.
Published: (2018-06-01) -
15-PGDH inhibition activates the splenic niche to promote hematopoietic regeneration
by: Julianne N.P. Smith, et al.
Published: (2021-03-01) -
Current status and developments in gene therapy for thalassemia and sickle cell disease
by: Evangelia Yannaki, et al.
Published: (2014-12-01) -
An Update in Drug-Induced Thrombotic Microangiopathy
by: Thomas Chatzikonstantinou, et al.
Published: (2020-05-01) -
β‐Thalassemia pathogenic variants in a cohort of children from the East African coast
by: Alexander W. Macharia, et al.
Published: (2020-07-01)